Literature DB >> 16435569

Correlation between quinolone uptakes by BCECs in vitro and brain-to-plasma concentration ratios in rats.

X D Liu1, D W Wang, L Xie.   

Abstract

Transport of 11 quinolones at the blood-brain barrier (BBB) was studied in vitro by using primarily cultured rat brain capillary endothelial cells (BCECs) and in vivo brain-to-plasma concentration ratios. In vitro, when cells reached confluence, a time course of quinolone uptake was recorded by incubation with a medium contraining quinolones 20 microg/ml at 37 degrees C. A simple two-compartment model was used for fitting the uptake time course and corresponding uptake parameters were estimated. In vivo rats were anesthetized, after in 10 mg/kg of quinoloes followed by infusion of 4 mg/kg/h for 2 hours, the drug concentrations in plasma and brain were measure and brain-to-plasma concentration ratios were calculated. Result showed that sparfloxacin and prulifloxacin have higher uptakes by BCECs and brain-to-plasma concentration ratios, compared with other quinolones, which indicated that the two drugs more easily penetrate into BBB. A good correlation between uptakes by BCECs and brain-to-plasma concentration ratios was found. These results demonstrated uptakes by BCECs in vitro might give prediction of brain-to-plasma ratio for quinolones.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16435569     DOI: 10.1007/BF03190628

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  11 in total

1.  Comparison of in vitro BBMEC permeability and in vivo CNS uptake by microdialysis sampling.

Authors:  D K Hansen; D O Scott; K W Otis; S M Lunte
Journal:  J Pharm Biomed Anal       Date:  2002-03-01       Impact factor: 3.935

2.  Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites.

Authors:  K Akahane; M Sekiguchi; T Une; Y Osada
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

3.  Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier.

Authors:  I Tamai; J Yamashita; Y Kido; A Ohnari; Y Sai; Y Shima; K Naruhashi; S Koizumi; A Tsuji
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Quantitative brain microdialysis study on the mechanism of quinolones distribution in the central nervous system.

Authors:  T Ooie; T Terasaki; H Suzuki; Y Sugiyama
Journal:  Drug Metab Dispos       Date:  1997-07       Impact factor: 3.922

Review 6.  The place of quinolones in everyday clinical practice.

Authors:  R C Moellering
Journal:  Chemotherapy       Date:  1996-03       Impact factor: 2.544

7.  Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier.

Authors:  M Murata; I Tamai; H Kato; O Nagata; A Tsuji
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

8.  Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs.

Authors:  T Ooie; H Suzuki; T Terasaki; Y Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  1996-08       Impact factor: 4.030

9.  In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors.

Authors:  A Saheki; T Terasaki; I Tamai; A Tsuji
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

10.  P-glycoprotein restricted transport of nimodipine across blood-brain barrier.

Authors:  Li Zhang; Xiao-Dong Liu; Lin Xie; Guang-Ji Wang
Journal:  Acta Pharmacol Sin       Date:  2003-09       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.